Periurethral transurethral microwave thermotherapy for the treatment of benign prostatic hyperplasia: An interim 1-year safety and efficacy analysis using the TherMatrx TMx-2000™

D. M. Albala; T. M.T. Turk; B. R. Fulmer; F. Koleski; G. Andriole; B. E. Davis; G. R. Eure; J. N. Kabalin; J. Lingeman; J. Nuzzarello; C. Sundaram

Periurethral transurethral microwave thermotherapy for the treatment of benign prostatic hyperplasia: An interim 1-year safety and efficacy analysis using the TherMatrx TMx-2000™

D. M. Albala, T. M.T. Turk, B. R. Fulmer, F. Koleski, G. Andriole, B. E. Davis, G. R. Eure, J. N. Kabalin, J. Lingeman, J. Nuzzarello, C. Sundaram

Research output: Contribution to journal › Article › peer-review

6 Scopus citations

Abstract

Transurethral microwave thermotherapy (TUMT) represents an accepted minimally invasive approach to the management of patients with benign prostatic hyperplasia (BPH). The TherMatrx TMx-2000 represents a further evolution in TUMT technique. This device uses periurethral transurethral microwave thermotherapy (P-TUMT) technology to directly target the BPH tissue adjacent to the prostatic urethra by using a catheter without a urethral-cooling surface. This article provides a technical review of the device and describes the results of a randomized, controlled multicenter study of P-TUMT for the treatment of symptomatic BPH. A discussion of the physiologic effects of P-TUMT is presented and compared to conventional TUMT. A comparison of P-TUMT to contemporary TUMT series in relation to efficacy and complications is also described. This study concludes that P-TUMT using the TherMatrx TMx-2000 device represents a minimally invasive, efficacious, and well-tolerated treatment for symptomatic BPH.

Original language	English
Pages (from-to)	288-293
Number of pages	6
Journal	Techniques in Urology
Volume	6
Issue number	4
State	Published - Dec 1 2000

Keywords

Benign prostatic hyperplasia
Microwave
Minimally invasive treatments
Thermotherapy
Transurethral microwave thermotherapy

Cite this

Albala, D. M., Turk, T. M. T., Fulmer, B. R., Koleski, F., Andriole, G., Davis, B. E., Eure, G. R., Kabalin, J. N., Lingeman, J., Nuzzarello, J., & Sundaram, C. (2000). Periurethral transurethral microwave thermotherapy for the treatment of benign prostatic hyperplasia: An interim 1-year safety and efficacy analysis using the TherMatrx TMx-2000™. Techniques in Urology, 6(4), 288-293.

@article{0cec26968639406da29da0ed81a97af5,

title = "Periurethral transurethral microwave thermotherapy for the treatment of benign prostatic hyperplasia: An interim 1-year safety and efficacy analysis using the TherMatrx TMx-2000{\texttrademark}",

abstract = "Transurethral microwave thermotherapy (TUMT) represents an accepted minimally invasive approach to the management of patients with benign prostatic hyperplasia (BPH). The TherMatrx TMx-2000 represents a further evolution in TUMT technique. This device uses periurethral transurethral microwave thermotherapy (P-TUMT) technology to directly target the BPH tissue adjacent to the prostatic urethra by using a catheter without a urethral-cooling surface. This article provides a technical review of the device and describes the results of a randomized, controlled multicenter study of P-TUMT for the treatment of symptomatic BPH. A discussion of the physiologic effects of P-TUMT is presented and compared to conventional TUMT. A comparison of P-TUMT to contemporary TUMT series in relation to efficacy and complications is also described. This study concludes that P-TUMT using the TherMatrx TMx-2000 device represents a minimally invasive, efficacious, and well-tolerated treatment for symptomatic BPH.",

keywords = "Benign prostatic hyperplasia, Microwave, Minimally invasive treatments, Thermotherapy, Transurethral microwave thermotherapy",

author = "Albala, {D. M.} and Turk, {T. M.T.} and Fulmer, {B. R.} and F. Koleski and G. Andriole and Davis, {B. E.} and Eure, {G. R.} and Kabalin, {J. N.} and J. Lingeman and J. Nuzzarello and C. Sundaram",

year = "2000",

month = dec,

day = "1",

language = "English",

volume = "6",

pages = "288--293",

journal = "Techniques in Urology",

issn = "1079-3259",

number = "4",

}

Albala, DM, Turk, TMT, Fulmer, BR, Koleski, F, Andriole, G, Davis, BE, Eure, GR, Kabalin, JN, Lingeman, J, Nuzzarello, J & Sundaram, C 2000, 'Periurethral transurethral microwave thermotherapy for the treatment of benign prostatic hyperplasia: An interim 1-year safety and efficacy analysis using the TherMatrx TMx-2000™', Techniques in Urology, vol. 6, no. 4, pp. 288-293.

TY - JOUR

T1 - Periurethral transurethral microwave thermotherapy for the treatment of benign prostatic hyperplasia

T2 - An interim 1-year safety and efficacy analysis using the TherMatrx TMx-2000™

AU - Albala, D. M.

AU - Turk, T. M.T.

AU - Fulmer, B. R.

AU - Koleski, F.

AU - Andriole, G.

AU - Davis, B. E.

AU - Eure, G. R.

AU - Kabalin, J. N.

AU - Lingeman, J.

AU - Nuzzarello, J.

AU - Sundaram, C.

PY - 2000/12/1

Y1 - 2000/12/1

N2 - Transurethral microwave thermotherapy (TUMT) represents an accepted minimally invasive approach to the management of patients with benign prostatic hyperplasia (BPH). The TherMatrx TMx-2000 represents a further evolution in TUMT technique. This device uses periurethral transurethral microwave thermotherapy (P-TUMT) technology to directly target the BPH tissue adjacent to the prostatic urethra by using a catheter without a urethral-cooling surface. This article provides a technical review of the device and describes the results of a randomized, controlled multicenter study of P-TUMT for the treatment of symptomatic BPH. A discussion of the physiologic effects of P-TUMT is presented and compared to conventional TUMT. A comparison of P-TUMT to contemporary TUMT series in relation to efficacy and complications is also described. This study concludes that P-TUMT using the TherMatrx TMx-2000 device represents a minimally invasive, efficacious, and well-tolerated treatment for symptomatic BPH.

AB - Transurethral microwave thermotherapy (TUMT) represents an accepted minimally invasive approach to the management of patients with benign prostatic hyperplasia (BPH). The TherMatrx TMx-2000 represents a further evolution in TUMT technique. This device uses periurethral transurethral microwave thermotherapy (P-TUMT) technology to directly target the BPH tissue adjacent to the prostatic urethra by using a catheter without a urethral-cooling surface. This article provides a technical review of the device and describes the results of a randomized, controlled multicenter study of P-TUMT for the treatment of symptomatic BPH. A discussion of the physiologic effects of P-TUMT is presented and compared to conventional TUMT. A comparison of P-TUMT to contemporary TUMT series in relation to efficacy and complications is also described. This study concludes that P-TUMT using the TherMatrx TMx-2000 device represents a minimally invasive, efficacious, and well-tolerated treatment for symptomatic BPH.

KW - Benign prostatic hyperplasia

KW - Microwave

KW - Minimally invasive treatments

KW - Thermotherapy

KW - Transurethral microwave thermotherapy

UR - http://www.scopus.com/inward/record.url?scp=0034489073&partnerID=8YFLogxK

M3 - Article

C2 - 11108568

AN - SCOPUS:0034489073

SN - 1079-3259

VL - 6

SP - 288

EP - 293

JO - Techniques in Urology

JF - Techniques in Urology

IS - 4

ER -

Periurethral transurethral microwave thermotherapy for the treatment of benign prostatic hyperplasia: An interim 1-year safety and efficacy analysis using the TherMatrx TMx-2000™

Abstract

Keywords

Other files and links

Fingerprint

Cite this